16
Apr 2026
Researchers at University College Dublin have discovered a previously unknown "courier system" that cells use to deliver coherent biological messages between each other, opening new possibilities for medicine and biotechnology.
16
Apr 2026
Scientists have found the strongest evidence to date that a condition known as Barrett's esophagus is the starting point for all cases of esophageal adenocarcinoma – the most common type of esophageal cancer in the developed world – even when telltale signs of this pre-cancerous stage are no longer visible.
16
Apr 2026
Research has shed important new light on the enemies-turned-allies that allow bacteria to exchange genes, including those linked to antimicrobial resistance (AMR).
16
Apr 2026
While it was previously thought that keratinocytes (skin cells) were only passive conductors that allow the rabies virus to pass through, novel research reveals that these cells play a much more active role. The findings of a new study in the Journal of Investigative Dermatology (JID), published by Elsevier, provide direct evidence that keratinocytes can support viral replication and transmit the rabies virus to neurons. The investigators offer a mechanistic explanation for how superficial skin exposures from scratches or minor bites by dogs and bats can lead to neuroinvasion, contributing to the risk of infection.
16
Apr 2026
Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new Cochrane review has found.
16
Apr 2026
Researchers from the Universitat Politècnica de València, the Francesc de Borja University Hospital in Gandia and the La Ribera University Hospital, through the Fisabio Foundation, have found that sunlight passing through windows in homes is neither a safe nor a recommended alternative for preventing or treating neonatal jaundice, a condition affecting more than half of all newborns.
16
Apr 2026
Cancer drugs are designed to shut tumors down. But sometimes, in the very act of attacking a tumor, treatment can also help a small fraction of cancer cells become harder to kill. A new study from researchers at the Institute for Systems Biology (ISB) shows that cancer cells may begin escaping therapy much earlier - as the therapy itself triggers a stress response that drives some cancer cells into a temporary drug-tolerant state.
16
Apr 2026
Efforts to identify and evaluate next-generation therapeutics for pediatric brain tumors are easily stymied by the quality and availability of laboratory models for research. To address this issue, scientists at St. Jude Children's Research Hospital developed patient-derived tumor organoids and tumor organoid xenografts that accurately reflect the biologic underpinnings of embryonal brain tumors.
16
Apr 2026
A new study published in The Journal of Nutrition, a peer-reviewed journal of the American Society for Nutrition, offers new insights into a decades-old puzzle in childhood obesity. The study found that while body mass index (BMI) starts to rise in early childhood during a stage known as adiposity rebound, when BMI increases after an initial decline, the waist-to-height ratio, a measure that better reflects body fat, continues to drop. This suggests that the BMI increase at this age mainly reflects growth in lean tissues such as muscle and bone, rather than extra body fat.
16
Apr 2026
Hamstring injuries are among the most common injuries in sports, particularly in activities involving sprinting and rapid acceleration. They account for roughly 10 % of injuries in field-based sports and often result in significant time away from competition. Despite their frequency, the mechanisms underlying the effectiveness of certain training programs in preventing these injuries remain poorly understood.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
